- +420 734 889 008
- info@twoknct.com
- 20 Wenlock Road, London, N1 7GU, England
Advancing Precision Oncology through Radiopharmaceutical Innovation & Targeted Radioligand Therapies
Radiopharmaceuticals & Targeted Radioligand Therapy Summit
Join us in Radiopharmaceuticals & Targeted Radioligand Therapy Summit
As targeted radioligand therapies gain momentum across oncology pipelines, the field is experiencing unprecedented growth
Welcome to The Radiopharmaceuticals & Targeted Radioligand Therapy Summit — The Radiopharmaceuticals & Targeted Radioligand Therapy Summit brings together senior leaders from pharma, biotech, nuclear medicine, radiochemistry, and healthcare to explore the rapid advancements transforming precision oncology.
As targeted radioligand therapies gain momentum across oncology pipelines, the field is experiencing unprecedented growth—driven by breakthroughs in isotope development, novel targeting mechanisms, and increasing clinical success in treating cancers such as prostate, neuroendocrine, and beyond.
However, challenges remain around isotope supply, manufacturing scalability, regulatory pathways, and global infrastructure. This summit is designed as a highly practical, discussion-led forum focused on overcoming these barriers, accelerating clinical development, and enabling broader patient access to next-generation radiopharmaceuticals.
Dr Stuart More
Acting Head of Division Nuclear Medicine
Michael Dornish, PhD
Chief Scientific Officer
SALLY WERNER
Chief Executive Officer
Pelin Parmaksizoğlu
Commercial Director
Catello Somma
Partner
Kemp Dolliver
Director of Research
Ira Goldman
VP, Global Public Policy & Government Affairs
Vincent Brechin
Head of Medical & Science
Dr. Behrooz H. Yousefi
Head of Radiopharmacy section at Nuclear Medicine
Akram Al-Ibraheem MD
FEBNM, DCBNC, FANMB, FRCPE Chairman, Department of Nuclear Medicine & PET/CT
Luke Brzozowski
University Health Network
Palma Rocchi
Inserm Research Director
Alison Armour
MB.ChB., BSc., MSc., MD., FRCR., FRCP. Founder & Chief Medical Officer
Who Should Attend
- Heads of Radiopharmaceuticals & Nuclear Medicine
- Oncology R&D & Clinical Development Leaders
- Radiochemists & Isotope Production Experts
- Manufacturing & Supply Chain Executives (Radioisotopes)
- Regulatory Affairs & Quality Leaders
- CDMO & CRO Executives in Radiopharma
- Hospital & Nuclear Medicine Specialists
- Biotech & Pharma Strategy Leaders
- Investors & Business Development Professionals
- Technology & Imaging Solution Providers
Industries Represented
- Pharmaceutical & Biotechnology Companies
- Radiopharmaceutical & Nuclear Medicine Specialists
- Isotope Production & Cyclotron Facilities
- Contract Development & Manufacturing Organisations (CDMOs)
- Hospitals & Clinical Research Centres
- Medical Imaging & Diagnostics Providers
- Regulatory & Government Bodies
- Supply Chain & Logistics (Radioactive Materials)
- Investment Firms & Strategic Advisors
Key Themes
Radiopharmaceutical Innovation & Pipeline Development
- Next-generation radioligand therapies and targets
- Expanding beyond prostate cancer into new indications
- Combination therapies and precision oncology strategies
Isotope Supply & Manufacturing Challenges
- Securing reliable isotope supply (Lu-177, Ac-225, Ga-68, etc.)
- Scaling production and global distribution networks
- Infrastructure and capacity constraints
Clinical Development & Trials
- Designing effective radiopharmaceutical clinical trials
- Patient selection and biomarker strategies
- Demonstrating efficacy and safety in targeted therapies
Regulatory Pathways & Market Access
- Navigating complex global regulatory frameworks
- Harmonisation challenges across regions
- Reimbursement strategies and pricing models
Supply Chain & Logistics for Radiopharma
- Handling, transport, and delivery of short half-life isotopes
- Cold chain and time-sensitive logistics
- Risk mitigation in highly specialised supply chains
Imaging, Diagnostics &Theranostics
- Integration of diagnostics and therapeutics (theranostics)
- Advances in PET/CT imaging technologies
- Enhancing patient outcomes through precision targeting
Partnerships, Investment & Commercialisation
- Strategic collaborations across pharma, biotech, and nuclear medicine
- Licensing, M&A, and investment trends
- Building scalable commercial radiopharmaceutical platforms
Future Outlook: Scaling Targeted Radioligand Therapies
- Expanding global access to radiopharmaceutical treatments
- Innovation in alpha therapies and novel isotopes
- Building a sustainable and scalable radiopharma ecosystem
Upcoming Events
T+1 Readiness Europe Summit 2027
Preparing Europe’s Capital Markets for T+1 Settlement: Operations, Technology, Liquidity & Post-Trade Readiness T+1 Readiness Europe Summit 2027 Join us...
Read MoreIndustrial Workforce & Skilled Trades…
Building the Skilled Workforce Behind Europe’s Industrial Future Industrial Workforce & Skilled Trades Europe Summit Join us in The Industrial...
Read MorePharma Tech Transfer & Scale-Up…
Accelerating Technology Transfer, Process Scale-Up & Commercial Manufacturing Excellence Across Pharmaceutical & Biopharmaceutical Production Pharma Tech Transfer & Scale-Up Summit...
Read MoreSports Venue Operations & Fan…
Building Smarter, Safer & More Connected Sports Venues Through Operational Excellence, Infrastructure Innovation & Enhanced Fan Experiences Sports Venue Operations...
Read MoreBattery Safety, Risk & Compliance…
Building Safer, Compliant & Resilient Battery Ecosystems Across Manufacturing, Storage, Transport & End-Use Applications Battery Safety, Risk & Compliance Summit...
Read MoreRadiopharmaceuticals & Targeted Radioligand Therapy…
Advancing Precision Oncology through Radiopharmaceutical Innovation & Targeted Radioligand Therapies Radiopharmaceuticals & Targeted Radioligand Therapy Summit Join us in Radiopharmaceuticals...
Read MoreT+1 Readiness Europe Summit 2027
Preparing Europe’s Capital Markets for T+1 Settlement: Operations, Technology, Liquidity & Post-Trade Readiness T+1 Readiness Europe Summit 2027 Join us...
Read MoreIndustrial Workforce & Skilled Trades…
Building the Skilled Workforce Behind Europe’s Industrial Future Industrial Workforce & Skilled Trades Europe Summit Join us in The Industrial...
Read MorePrevious Events
Delegate satisfaction rate
0
Expert Speakers
0
Panel Discussions
0
Focused Driven Day
0
6 Key Themes for the Radiopharmaceuticals & Targeted Radioligand Therapy Summit
6 Reasons to Attend
- Accelerate Radiopharmaceutical Innovation: Gain insights into cutting-edge developments in targeted radioligand therapies and precision oncology.
- Overcome Isotope Supply Constraints: Understand how to secure, scale, and optimise isotope production and distribution.
- Advance Clinical Development Strategies: Learn best practices for designing and executing successful radiopharmaceutical trials.
- Navigate Complex Regulatory Landscapes: Stay ahead of evolving global regulatory and reimbursement frameworks.
- Strengthen Specialised Supply Chains: Explore solutions for managing the unique logistics and infrastructure challenges of radiopharma.
- Connect with Industry Leaders: Build relationships with key stakeholders across pharma, biotech, nuclear medicine, and investment.
Radiopharmaceuticals & Targeted Radioligand Therapy Summit
However, challenges remain around isotope supply, manufacturing scalability, regulatory pathways, and global infrastructure. This summit is designed as a highly practical, discussion-led forum focused on overcoming these barriers, accelerating clinical development, and enabling broader patient access to next-generation radiopharmaceuticals.
Radiopharmaceuticals & Targeted Radioligand Therapy Summit
Get in touch for Group Discounted Tickets
Book An Exhibition Stand + 2 Delegate Passes: Book Now For Just: 4,999 €
Discover how you can be a part of this exciting conference and get your expertise in front of your target audience. Packages Include; Exhibition Area, Main Stage Speaking, One-To-One Meetings.
Twoknct Media & Publishing we have exciting offers and news about our upcoming events that we hope you’d like to hear about! We will use your information to predict what you might be interested in. Please remember to check your junk folder for the brochure – and add info@twoknctmedia.com to your safe senders list.
Get in touch for Group Discounted Tickets
To register your team now and benefit from huge group savings, call the conference team on +420 776 164 009 (Prague office) || +44 2038 076 227 (London office)
* We hope you’d like to hear about! We will use your information to predict what you might be interested in.
Venue Details
Join Radiopharmaceuticals & Targeted Radioligand Therapy Summit
Sponsors & Partners
